DIHEXA Beverly Hills Rejuvenation Center The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Frontiers A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases Frontiers Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain